Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeHealthFDA Issues Warning Letters to Companies Marketing Unapproved Eye Products

FDA Issues Warning Letters to Companies Marketing Unapproved Eye Products

Add to Favorite
Added to Favorite
Photo by Karolina Grabowska

Eight businesses, including pharmacy behemoths CVS Health Corp (CVS.N) and Walgreens Boots Alliance (WBA.O), were issued a warning by the U.S. Food and Drug Administration on Tuesday against producing or selling unapproved eye medications.

Eight businesses have received warning letters from the U.S. Food and medicine Administration for producing or selling illegal ophthalmic medicine items in contravention of federal law. The agency’s ongoing campaign to safeguard Americans from potentially dangerous ophthalmic goods includes these warning letters.

The eight warning letters discuss the illegal marketing of eye treatments for the treatment of diseases such conjunctivitis (also known as “pink eye”), cataracts, glaucoma, and others. A few of the FDA warning letters also name the companies in question for sterility-related product quality problems.

The FDA reports, “The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses. Some of these eye products are labeled to contain silver, which may be characterized as silver sulfate, silver sulphate or argentum. Long-term use of drugs containing silver can cause some areas of the skin and other body tissues, including in the eye, to permanently turn gray or blue-gray, which is called “argyria.” Additionally, unapproved drugs that claim to cure, treat or prevent serious conditions may cause consumers to delay or stop medical treatments that have been found safe and effective through the FDA review process.” Source FDA.gov

In addition, the FDA reports, The agency issued warning letters to the following companies:

Consumers currently using eye products included in these warning letters should speak to their health care professional. The FDA encourages consumers and health care professionals to report any adverse reaction to the agency’s MedWatch program.

The FDA has asked the companies to respond within 15 days of receipt of the letters, stating how they will correct the violations. Failure to correct the violations promptly may result in the FDA pursuing legal action, including product seizure and/or a court order requiring a company to stop manufacturing and distributing an unapproved product. Additionally, the agency has placed some of these companies on import alert to help stop their products from entering the U.S. and reaching consumers.

The FDA’s investigation of eye products is ongoing, and the agency may take additional regulatory or enforcement actions, as warranted.

Celebrity WEB Update— Premier Jewelry designer and manufacturer fashion house ParisJewelry.com has started manufacturing a new custom line of celebrity jewelry designs with 30% Off and Free Shipping. Replenish Your Body- Refilter Your Health with OrganicGreek.com Vitamin Bottles, Vitamins and Herbs. Become a  WebFans  Creator and Influencer.

 

 

Subscribe to get Latest News Updates

Latest News

You may like more
more

CWEB Reports: Biden-Harris Administration ‘Closely Monitoring’ Mpox Spread – 5 Key Facts from CDC”

The Biden-Harris administration is closely monitoring the outbreak of...

CWEB informs web fans on recall poultry products from Boars Head

Boar’s Head Provisions Co. Inc. has expanded its July...

Fake Therapist Fooled Hundreds Online Until She Died, State Records Say

July 2, 2024 Hundreds of Americans may have unknowingly...